V. G. Viana, “ORAL GLP-1 RECEPTOR AGONIST (ORFORGLIPRON) IN THE MANAGEMENT OF OBESITY AND TYPE 2 DIABETES”, Editora, pp. 43–55, Jan. 2026, Accessed: Mar. 04, 2026. [Online]. Available: https://sevenpubl.com.br/editora/article/view/8968